Behavioral Coaching Intervention (Laguna Health) for Patients With Cancer
NCT ID: NCT06004141
Last Updated: 2024-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
18 participants
INTERVENTIONAL
2023-08-30
2024-01-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Laguna Health intervention has several components:
1. Post-Discharge Recovery Coaching with a Laguna Health recovery coach to help patients identify barriers to post-discharge recovery
2. Digital psycho-educational content tailored to the needs of patients with cancer
3. Personal healthcare summaries
4. Digital content and coaching on behavioral strategies to promote self-efficacy
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Self Management and Support for Adolescents and Young Adults With Cancer
NCT03130751
Feasibility, Acceptability, and Preliminary Efficacy of a Remotely-delivered Health Coaching Intervention for Cancer Survivors
NCT07026214
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors
NCT05674578
Comprehensive Outcomes for After Cancer Health
NCT05349227
Feasibility of Health Coaching in Cancer Patients
NCT02556528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Laguna Health is behavioral coaching intervention wherein patients and their caregivers are paired with a Laguna Health recovery coach to promote post-discharge recovery. Additionally, Laguna Health offers patients and their caregivers access to a mobile platform containing psycho-educational content, healthcare summaries, and interactive features such as journaling and task lists.
Participants will be randomized in 1:1 fashion to one of the two study groups: Laguna Health + usual care versus usual care alone, stratified by cancer type and therapy intent (curable solid tumor vs. incurable GI cancer vs. incurable other solid tumor vs hematologic malignancy).
Participants randomly assigned to the Laguna Health group will receive access to the Laguna Health recovery coach and mobile platform for 12 weeks after they are discharged from the hospital.
Participants randomly assigned to the usual care group will receive usual post-hospital discharge care as arranged by their inpatient oncology team. They will not be given access to the Laguna Health intervention.
In both groups, participants are asked to complete questionnaires at baseline, weeks 6, weeks 12 and weeks 24 after enrolling in the study.
It is expected that 80 patients and at most 80 caregivers will take part in this study.
Laguna Health, Inc. is supporting this research study by providing funding.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laguna Health Group
* Patient and caregiver participants will have access to Laguna Health coaching and the Laguna Health mobile platform for 12 weeks after discharge from the hospital to a home environment.
* Patient participants will receive usual post-discharge care as arranged by their inpatient and outpatient oncology teams.
* Patient participants will complete study questionnaires to assess their quality of life, symptoms, and psychological outcomes.
* Caregiver participants will complete study questionnaires to assess their quality of life and caregiving burden.
* 10-20 participants will complete exit interviews to ascertain more feedback on the Laguna Health intervention.
Laguna Health
Laguna Health is a novel behavioral coaching intervention (Laguna Health) that provides supportive care to patients with cancer who are discharged from the hospital and their caregivers. The intervention includes four components: 1) behavioral coaching with a Laguna Health recovery coach; 2) digital psycho-educational content tailored to the needs of patients with cancer; 3) summary of post-discharge care tasks; and 4) behavioral strategies to promote self-efficacy.
Usual Care
* Participants will receive usual post-hospital discharge care as arranged by their inpatient and outpatient oncology care teams.
* Patient participants will complete study questionnaires to assess their quality of life, symptoms, and psychological outcomes.
* Caregiver participants will complete study questionnaires to assess their quality of life and caregiving burden.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laguna Health
Laguna Health is a novel behavioral coaching intervention (Laguna Health) that provides supportive care to patients with cancer who are discharged from the hospital and their caregivers. The intervention includes four components: 1) behavioral coaching with a Laguna Health recovery coach; 2) digital psycho-educational content tailored to the needs of patients with cancer; 3) summary of post-discharge care tasks; and 4) behavioral strategies to promote self-efficacy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with cancer being treated with curative intent per chemotherapy order entry, treatment intent designation and or trial consent forms OR based on documentation in the oncology clinic notes.
* Patients with cancer being treated with palliative intent (per chemotherapy order entry, treatment intent designation and or trial consent forms OR based on documentation in the oncology clinic notes for those not receiving chemotherapy) who are experiencing their first or second hospitalization for cancer related care or complications.
* Unplanned or non-elective hospitalization at Massachusetts General Hospital (MGH)
* Planned discharge to a home environment.
* Receiving outpatient care at the MGH Cancer Center
* Access to a smartphone capable of accessing Laguna Health's app on Android or iOS
* Ability to comprehend, read, and respond to questions in English.
Exclusion Criteria
* Patients with planned discharge to hospice or care facility other than home.
* Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures
Caregiver Eligibility
* Adult (\> 18 years) relative or friend of a patient who agrees to participate in the study whom the patient identified as living with them or having in-person contact with them at least twice per week.
* Ability to comprehend, read, and respond to questions in English as Laguna Health is only available in English in this proof-of-concept study.
* Access to a smartphone capable of accessing Laguna Health's app on Android or iOS
Note that patients can enroll without an eligible caregiver.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laguna Health, Inc
INDUSTRY
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tejaswini M. Dhawale, MD
Instructor in Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tejaswini Dhawale, MD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-358
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.